SCHEMBL2516366

SCHEMBL2516366

C=C(C)C(=O)OCC1CC2CC1CC2[Si](OC)(OC)OC

nearest known ligand 0.43

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.43
▸ TSHR P16473 3/20 0.33
▸ THRB P10828 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17829494 0.80 ALDH1A1 (0.49) ALDH1A1TSHRTHRB
SCHEMBL2515247 0.80 TSHR (0.33) ALDH1A1TSHR
SCHEMBL10064091 0.79 ALDH1A1 (0.47) ALDH1A1TSHRTHRB
SCHEMBL18400936 0.75 ALDH1A1 (0.44) ALDH1A1TSHRTHRB
SCHEMBL18850131 0.75 ALDH1A1 (0.44) ALDH1A1TSHRTHRB
SCHEMBL10150616 0.74 ALDH1A1 (0.56) ALDH1A1TSHRTHRB
SCHEMBL19718945 0.74 ALDH1A1 (0.43) ALDH1A1TSHRTHRB
SCHEMBL18400941 0.74 ALDH1A1 (0.43) ALDH1A1TSHRTHRB
SCHEMBL13790804 0.73 — —
SCHEMBL22201837 0.73 LTA4H (0.31) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8283486-B2 Norbornane skeleton structure-containing organosilicon compound and method of producing same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-10-09 — — US disclosed
EP-2450363-A2 Norbornane skeleton structure-containing organosilicon compound and method of producing same Shin-Etsu Chemical Co., Ltd. (JP) 2012-05-09 — — EP disclosed
US-8034965-B2 Norbornane skeleton structure-containing organosilicon compound and method of producing same SHIN-ETSU CHEMICAL CO., LTD. (JP) 2011-10-11 — — US disclosed
US-20110245525-A1 NORBORNANE SKELETON STRUCTURE-CONTAINING ORGANOSILICON COMPOUND AND METHOD OF PRODUCING SAME SHIN-ETSU CHEMICAL CO., LTD. (JP) 2011-10-06 — — US disclosed
US-20090124821-A1 NORBORNANE SKELETON STRUCTURE-CONTAINING ORGANOSILICON COMPOUND AND METHOD OF PRODUCING SAME SHIN-ETSU CHEMICAL CO., LTD. (JP) 2009-05-14 — — US disclosed
EP-2058316-A2 Norbornane skeleton structure-containing organosilicon compound and method of producing same Shin-Etsu Chemical Co., Ltd. (JP) 2009-05-13 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090124821-A1 NORBORNANE SKELETON STRUCTURE-CONTAINING ORGANOSILICON COMPOUND AND METHOD OF PRODUCING SAME NOTUM, PFAS, WEE1 ALDH1A1 917/4885TSHR 4844/4885THRB 4556/4885
US-20110245525-A1 NORBORNANE SKELETON STRUCTURE-CONTAINING ORGANOSILICON COMPOUND AND METHOD OF PRODUCING SAME NOTUM, PFAS, WEE1 ALDH1A1 917/4885TSHR 4844/4885THRB 4556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback